These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 25592241)

  • 1. The Metabolic Risk in Patients Newly Diagnosed with Acromegaly Is Related to Fat Distribution and Circulating Adipokines and Improves after Treatment.
    Olarescu NC; Heck A; Godang K; Ueland T; Bollerslev J
    Neuroendocrinology; 2016; 103(3-4):197-206. PubMed ID: 25592241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower visceral and subcutaneous but higher intermuscular adipose tissue depots in patients with growth hormone and insulin-like growth factor I excess due to acromegaly.
    Freda PU; Shen W; Heymsfield SB; Reyes-Vidal CM; Geer EB; Bruce JN; Gallagher D
    J Clin Endocrinol Metab; 2008 Jun; 93(6):2334-43. PubMed ID: 18349062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations between the expression of the insulin sensitizing hormones, adiponectin, visfatin, and omentin, and the appetite regulatory hormone, neuropeptide Y and its receptors in subcutaneous and visceral adipose tissues.
    Nway NC; Sitticharoon C; Chatree S; Maikaew P
    Obes Res Clin Pract; 2016; 10(3):256-63. PubMed ID: 26067914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory adipokines contribute to insulin resistance in active acromegaly and respond differently to different treatment modalities.
    Olarescu NC; Ueland T; Godang K; Lindberg-Larsen R; Jørgensen JO; Bollerslev J
    Eur J Endocrinol; 2014 Jan; 170(1):39-48. PubMed ID: 24092547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between body composition, circulating interleukin-1 receptor antagonist, osteocalcin, and insulin metabolism in active acromegaly.
    Ueland T; Fougner SL; Godang K; Lekva T; Schurgers LJ; Scholz H; Halvorsen B; Schreiner T; Aukrust P; Bollerslev J
    J Clin Endocrinol Metab; 2010 Jan; 95(1):361-8. PubMed ID: 19880791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body fat distribution and circulating adipsin are related to metabolic risks in adult patients with newly diagnosed growth hormone deficiency and improve after treatment.
    Wang Y; Zheng X; Xie X; Qian W; Ren Z; Chen Y; Wu X; Liao K; Ren W
    Biomed Pharmacother; 2020 Dec; 132():110875. PubMed ID: 33254428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentrations of omentin and vaspin versus insulin resistance in obese individuals.
    Sperling M; Grzelak T; Pelczyńska M; Jasinska P; Bogdanski P; Pupek-Musialik D; Czyzewska K
    Biomed Pharmacother; 2016 Oct; 83():542-547. PubMed ID: 27449535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Association Between Serum Vaspin and Omentin-1 Levels in Obese Children with Metabolic Syndrome.
    Buyukinan M; Atar M; Can U; Pirgon O; Guzelant A; Deniz I
    Metab Syndr Relat Disord; 2018 Mar; 16(2):76-81. PubMed ID: 29319392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visceral adiposity index is associated with insulin sensitivity and adipocytokine levels in newly diagnosed acromegalic patients.
    Ciresi A; Amato MC; Pizzolanti G; Giordano Galluzzo C
    J Clin Endocrinol Metab; 2012 Aug; 97(8):2907-15. PubMed ID: 22679062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipocytes as a source of increased circulating levels of nicotinamide phosphoribosyltransferase/visfatin in active acromegaly.
    Olarescu NC; Ueland T; Lekva T; Dahl TB; Halvorsen B; Aukrust P; Bollerslev J
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1355-62. PubMed ID: 22319029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between adiponectin, visfatin, and omentin in subcutaneous and visceral adipose tissues and serum, and correlations with clinical and peripheral metabolic factors.
    Sitticharoon C; Nway NC; Chatree S; Churintaraphan M; Boonpuan P; Maikaew P
    Peptides; 2014 Dec; 62():164-75. PubMed ID: 25453978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of serum vaspin levels and vaspin expression in adipose tissue and smooth muscle tissue in pregnant women with and without gestational diabetes.
    Tang Y; Qiao P; Qu X; Bao Y; Li Y; Liao Y; Ying H
    Clin Endocrinol (Oxf); 2017 Oct; 87(4):344-349. PubMed ID: 28636750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum visfatin levels in acromegaly: Correlation with disease activity and metabolic alterations.
    Ciresi A; Amato MC; Pizzolanti G; Giordano C
    Growth Horm IGF Res; 2015 Oct; 25(5):240-6. PubMed ID: 26188992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of growth hormone deficiency on body composition and biomarkers of cardiovascular risk after definitive therapy for acromegaly.
    Lin E; Wexler TL; Nachtigall L; Tritos N; Swearingen B; Hemphill L; Loeffler J; Biller BM; Klibanski A; Miller KK
    Clin Endocrinol (Oxf); 2012 Sep; 77(3):430-8. PubMed ID: 22315983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body Composition and Ectopic Lipid Changes With Biochemical Control of Acromegaly.
    Bredella MA; Schorr M; Dichtel LE; Gerweck AV; Young BJ; Woodmansee WW; Swearingen B; Miller KK
    J Clin Endocrinol Metab; 2017 Nov; 102(11):4218-4225. PubMed ID: 28945897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abdominal fat deposits determined by magnetic resonance imaging in relation to leptin and vaspin levels as well as insulin resistance in the general adult population.
    Genske F; Kühn JP; Pietzner M; Homuth G; Rathmann W; Grabe HJ; Völzke H; Wallaschofski H; Friedrich N
    Int J Obes (Lond); 2018 Feb; 42(2):183-189. PubMed ID: 28925406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pegvisomant increases intra-abdominal fat in patients with acromegaly: a pilot study.
    Plöckinger U; Reuter T
    Eur J Endocrinol; 2008 Apr; 158(4):467-71. PubMed ID: 18362292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relation of omentin gene expression and glucose homeostasis of visceral and subcutaneous adipose tissues in non-diabetic adults.
    Daneshafrooz A; Yuzbashian E; Zarkesh M; Asghari G; Mirmiran P; Hedayati M; Abooshahab R; Fanaei SM; Khalaj A
    Mol Biol Rep; 2022 Jan; 49(1):163-169. PubMed ID: 34739694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timed-daily ingestion of whey protein and exercise training reduces visceral adipose tissue mass and improves insulin resistance: the PRISE study.
    Arciero PJ; Baur D; Connelly S; Ormsbee MJ
    J Appl Physiol (1985); 2014 Jul; 117(1):1-10. PubMed ID: 24833780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of vaspin and apelin levels with insulin resistance and atherosclerosis in metabolic syndrome.
    Karbek B; Bozkurt NC; Topaloglu O; Aslan MS; Gungunes A; Cakal E; Delibasi T
    Minerva Endocrinol; 2014 Jun; 39(2):99-105. PubMed ID: 24736484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.